New bio-adhesive polymer demonstrated in JoVE

October 25, 2012 in Medical research

New bio-adhesive polymer demonstrated in JoVE

A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales. Chitosan is a polymer derived from chitin, which is found in fungal cell walls or in exoskeletons of crustaceans and insects.This molecular component allows SurgiLux to form low energy bonds between the polymer and the desired tissue when it absorbs light. The technology may soon replace traditional sutures in the clinic.

For thousands of years, clinicians have been using sutures to close open wounds and help repair torn tissues. Dr. L. John Foster from the University of New South Wales explains that, "though sutures have a superior strength to SurgiLux, sutures are physically invasive and do not support . SurgiLux is a thin film, so you do not end up with any physical invasion or further damage to the tissue, thus allowing more complete healing." This is beneficial when repairing delicate tissues like neurons or blood vessels.

The SurgiLux polymer has two valuable properties: it can achieve a uniform seal when activated by a laser, and has attributable to the chitosan base. Together, these features prevent the wound from becoming infected and maintain a barrier between the tissue and its surroundings. A suture would require extensive bandaging to achieve the same results. The polymer is particularly useful for hard-to-operate tissues or organs, such as the eye. "We are exploring ophthalmology as a venue for SurgiLux in human patients. SurgiLux can be readily applied to the eye during surgery, and can seal the cornea in place during keratoplasty when sutures cannot," tells Dr. Foster.

Dr. Foster and his team chose to publish in JoVE to expedite adoption of the technology. While the concept of SurgiLux has been previously published, this is the first demonstration of its application with the laser. "Many surgeons want to adopt it immediately. However, people don't know how to use the lasers. JoVE can visually show that this is not a difficult system and that any group with a basic background in biochemistry can buy a laser and get to work testing SurgiLux."

More information: www.jove.com/video… ive-surgilux

Journal reference: Journal of Visualized Experiments search and more info website

Provided by The Journal of Visualized Experiments

5 /5 (2 votes)  

Rank 5 /5 (2 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

Medical research created 14 hours ago | popularity 5 / 5 (3) | comments 0 | with audio podcast

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Medical research created May 17, 2013 | popularity 4 / 5 (4) | comments 0 | with audio podcast

SUMO wrestling cells reveal new protective mechanism target for stroke

Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.

Medical research created May 17, 2013 | popularity 5 / 5 (1) | comments 0

How serotonin receptors can shape drug effects, from LSD to migraine medication

New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...

Medical research created May 17, 2013 | popularity 4 / 5 (1) | comments 0 | with audio podcast

Preventing blood poisoning

Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.

Medical research created May 17, 2013 | popularity 4 / 5 (1) | comments 0 | with audio podcast


Blame your parents for bunion woes

A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. Findings from the Framingham Foot ...

Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak

Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.

Treatment of sleep apnea improves glucose levels in prediabetes

Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in ...

Commonly used catheters double risk of blood clots in ICU and cancer patients

Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.

Molecular marker from pancreatic 'juices' helps identify pancreatic cancer

Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis—two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic ...

Genetic diversity within tumors predicts outcome in head and neck cancer

A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue ...